z-logo
Premium
Reply to Lack of reliability of CA125 response criteria with anti‐VEGF molecularly targeted therapy
Author(s) -
Azad Nilofer,
Minasian Lori,
Kohn Elise
Publication year - 2008
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.23894
Subject(s) - medicine , clinical trial , oncology , targeted therapy , cancer , prostate cancer , disease , clinical endpoint , randomized controlled trial

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom